Relmada Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $136k | 20k | 6.95 |
| 2024-12-31 | $65k | 125k | 0.52 |
| 2024-09-30 | $351k | 108k | 3.24 |
| 2024-06-30 | $324k | 108k | 3.00 |
| 2024-03-31 | $480k | 103k | 4.65 |
| 2023-12-31 | $764k | 185k | 4.14 |
| 2023-09-30 | $586k | 195k | 3.00 |
| 2023-06-30 | $668k | 272k | 2.46 |
| 2023-03-31 | $141k | 63k | 2.25 |
| 2022-12-31 | $428k | 123k | 3.49 |
| 2021-12-31 | $393k | 17k | 22.55 |